The Patent Finder
US

Nucleoside Derivatives as Inhibitors of RNA-Dependent RNA Viral Polymerase

US 8,481,712 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Merck Sharp & Dohme LLC, which filed it. The recorded assignments below show how it moved.

Term ends Jan 22, 2027 · Medium confidence

Held by Merck Sharp & Dohme LLC
Filed Feb 2, 2007 · Granted Jul 9, 2013
Base term plus 1830 days of PTA
Today
20 years from filing
2002 2027
Clock starts
Jan 18, 2002
Term ends
Jan 22, 2027
Granted
Jul 9, 2013
base term patent term adjustment fee events Updated Nov 1, 2026 · includes USPTO assignment & status data published Nov 1, 2026 and grant & fee data published Oct 27, 2026 (weekly) · how we know
1,830
Days of term adjustment
Read from the USPTO PTA record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Applications in this family
Applications sharing this one's continuity chain.

This patent's term runs 1830 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 18, 2002Jan 18, 2022High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+1830 days, USPTO PTA recordJan 22, 2027High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 22, 2027Medium confidence

This family

US 6,777,395Expired (term)
Jun 2022
Jun 2022
Application PCT/US2002/003086Pending
not computed
not computed
Application PCT/US2002/001531PCT application
no patent term
no patent term
US 7,125,855Expired (term)
Jun 2022
Jun 2022
US 7,105,499Expired (term)
Dec 2022
Dec 2022
US 7,202,224Expired (term)
Jan 2022
Jan 2022
Application 11/643,464Abandoned
not computed
not computed
US 8,481,712this patent
Jan 2027
Jan 2027
8 of 14 applications in this family shown, earliest filings first.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 26, 2010
Reel 23906, frame 803
Merck & Co., Inc.Merck Sharp & Dohme Corp.Change of Name
Aug 27, 2012
Reel 28850, frame 515
Merck Sharp & Dohme Corp.Schering CorporationMerger
Aug 29, 2012
Reel 28866, frame 511
Schering CorporationMerck Sharp & Dohme Corp.Change of Name
Jun 28, 2017
Reel 43029, frame 338
Isis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.Change of Name
Aug 8, 2022
Reel 61102, frame 145
Merck Sharp & Dohme Corp.Merck Sharp & Dohme LLCMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

Maintenance fee events come from USPTO's own fee records. USPTO does not publish a per-patent fee page, so there is nothing to link to.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.

What's changing

Note
The 1830 days of PTA are read from the USPTO record, not recalculated by us

Citations

42
later US patents cite this one
That is top 25% of utility patents granted in 2013 in our data, the only group it is compared against. How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 1, 2026 · includes USPTO assignment & status data published Nov 1, 2026 and grant & fee data published Oct 27, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited